GL

Gregory Alan Lazar

XE Xencor: 84 patents #3 of 104Top 3%
Genentech: 6 patents #494 of 2,392Top 25%
EL Eli Lilly: 4 patents #824 of 2,858Top 30%
CP Chugai Pharmaceutical: 2 patents #485 of 1,238Top 40%
AD Adimab: 1 patents #37 of 60Top 65%
📍 Pacifica, CA: #4 of 576 inventorsTop 1%
🗺 California: #2,521 of 386,348 inventorsTop 1%
Overall (All Time): #16,293 of 4,157,543Top 1%
94
Patents All Time

Issued Patents All Time

Showing 26–50 of 94 patents

Patent #TitleCo-InventorsDate
10113001 Fc variants with increased affinity for FcyRIIc Wei Dang, John Desjarlais, Sher Bahadur Karki, Omid Vafa, Robert Hayes 2018-10-30
9914778 Methods and compositions for inhibiting CD32B expressing cells Seung Chu, John Desjarlais, Sher Bahadur Karki, Gregory Moore, Igor Vostiar 2018-03-13
9902773 Methods and compositions for inhibiting CD32b expressing cells Seung Chu, John Desjarlais, Sher Bahadur Karki, Gregory Moore, Igor Vostiar 2018-02-27
9855318 Fusion proteins David Bruce Baldwin, John Michael Beals, Jonathan Day, Craig Duane Dickinson, Andrew Ihor Korytko 2018-01-02
9803020 Optimized antibodies that target CD19 Matthew Bernett, Seung Chu, John Desjarlais, Sher Bahadur Karki, Erik Weiking Pong +2 more 2017-10-31
9803023 Fc variants with altered binding to FcRn Aaron Keith Chamberlain, John Desjarlais, Sher Bahadur Karki, Jost Vielmetter, Sean C. Yoder 2017-10-31
9714282 Optimized Fc variants and methods for their generation Arthur J. Chirino, Wei Dang, John Desjarlais, Stephen K. Doberstein, Robert Hayes +2 more 2017-07-25
9708406 Anti-transferrin receptor antibodies and methods of use Yin Zhang, Joy Yu Zuchero, Jasvinder Atwal, Jessica Couch, Mark S. Dennis +2 more 2017-07-18
9663582 Optimized Fc variants Wei Dang, John Desjarlais, Sher Bahadur Karki, Omid Vafa, Robert Hayes +1 more 2017-05-30
9657106 Optimized Fc variants Wei Dang, John Desjarlais, Sher Bahadur Karki, Omid Vafa, Robert Hayes +1 more 2017-05-23
9605061 Antibodies with modified isoelectric points Bassil Dahiyat, Matthew Bernett 2017-03-28
9574006 Optimized anti-CD30 antibodies John Desjarlais, Philip W. Hammond, David F. Carmichael, Bao-Lu Chen, Seung Chu +2 more 2017-02-21
9493578 Compositions and methods for simultaneous bivalent and monovalent co-engagement of antigens Gregory Moore 2016-11-15
9475881 Antibody variants with enhanced complement activity Sher Bahadur Karki, Gregory Moore 2016-10-25
9394366 Methods and compositions for inhibiting CD32B expressing cells Seung Chu, John Desjarlais, Sher Bahadur Karki, Gregory Moore, Igor Vostiar 2016-07-19
9371397 CTLA4-Ig immunoadhesins Matthew Bernett 2016-06-21
9353187 Optimized FC variants and methods for their generation Arthur J. Chirino, Wei Dang, John Desjarlais, Stephen K. Doberstein, Robert Hayes +2 more 2016-05-31
9260523 Methods and compositions for inhibiting CD32b expressing cells Seung Chu, John Desjarlais, Sher Bahadur Karki, Gregory Moore, Igor Vostiar 2016-02-16
9200079 Fc variants with altered binding to FcRn Aaron Keith Chamberlain, John Desjarlais, Sher Bahadur Karki, Jost Vielmetter, Sean C. Yoder 2015-12-01
9193798 Optimized Fc variants and methods for their generation Arthur J. Chirino, Wei Dang, John Desjarlais, Stephen K. Doberstein, Robert Hayes +2 more 2015-11-24
9102739 Anti-glypican-3 antibody Bassil Dahiyat, Hisafumi Okabe, Masamichi Sugimoto, Shigeyuki Iijima, Izumi Sugo 2015-08-11
9079960 Methods and compositions for inhibiting CD32B expressing cells Seung Chu, John Desjarlais, Sher Bahadur Karki, Gregory Moore, Igor Vostiar 2015-07-14
9051373 Optimized Fc variants Wei Dang, John Desjarlais, Sher Bahadur Karki, Omid Vafa, Robert Hayes +1 more 2015-06-09
9040042 Optimized antibodies that target HM1.24 Matthew Bernett, John Desjarlais, Sher Bahadur Karki, Umesh Muchhal, Duc-Hanh Thi Nguyen +1 more 2015-05-26
9040041 Modified FC molecules John Desjarlais, Sher Bahadur Karki, John O. Richards, Gregory Moore, David F. Carmichael 2015-05-26